Chicago-based Cardiosense has received 510(k) clearance from the FDA for its CardioTag device, a multimodal wearable sensor.
The CardioTag is designed to provide clinicians with a comprehensive, noninvasive view of cardiac function by simultaneously measuring electrocardiogram, photoplethysmogram and seismocardiogram data. The device also reports heart rate and pulse rate, according to a July 30 Diagnostic and Interventional Cardiology report.
The device will also support future development of AI-powered cardiovascular monitoring tools. Cardiosense plans to pair CardioTag with algorithms to estimate metrics such as pulmonary capillary wedge pressure, pending further regulatory approval, according to the report.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
